Compliance & Validation — Documented
GxP validated, SOC 2 Type II, ISO 27001, 21 CFR Part 11, GDPR
Clario
Clinical trial endpoint technology company providing eCOA, cardiac safety, imaging, and respiratory data solutions.
Clario was formed in 2021 through the merger of ERT (established 1972) and Bioclinica, and is headquartered in Philadelphia, Pennsylvania. The company provides endpoint data collection technologies for clinical trials — including electronic clinical outcome assessments (eCOA), cardiac safety, medical imaging, and respiratory solutions — used by sponsors and CROs across decentralized, hybrid, and site-based studies. Clario holds ISO 27001:2022 certification and SOC 2 Type II attestation, and delivers its trial platforms for regulated GxP environments with 21 CFR Part 11 support. In March 2026 Clario was acquired by Thermo Fisher Scientific and now operates under the Clario brand within Thermo Fisher's Laboratory Products and Biopharma Services segment.
- Headquarters
- Philadelphia, United States
- Founded
- 2021
- Compliance
- SOC 2 Type II, ISO 27001, 21 CFR Part 11, GxP, GDPR
- Deployment options
- cloud
- Website
- https://clario.com
- https://www.linkedin.com/company/clario-inc
Categories
AI Use Cases
- Clinical Data Management
- Digital/Decentralized Trials
- Medical Monitoring & Safety Review
Vendor Scorecard
64% — Partial coverage. Coverage score — how completely Atlas documents Clario across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management
Solution Scope — Documented
Clinical Data Management
Company Viability — Partially documented
Private, Founded 2021
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- Which endpoint modalities (eCOA, cardiac safety, imaging, respiratory) does our protocol need, and how are they combined?
- How does endpoint data flow into our EDC and data management systems?
- What validation and Part 11 documentation is provided per study?
- How are patient-facing devices provisioned and supported across regions?